Congenital heart diseases and their association with the variant distribution features on susceptibility genes

W Su1, P Zhu1, R Wang2

  • 1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Clinical Genetics
|July 19, 2016
PubMed

Insights

Genetic variants in NKX2-5, GATA4, and TBX5 genes are linked to specific congenital heart disease (CHD) subtypes. Understanding these genetic variations can help predict infant CHD risks.

Area of Science:

  • Genetics
  • Cardiology
  • Developmental Biology

Background:

  • Congenital heart disease (CHD) is a major cause of childhood illness and death.
  • Genetic and environmental factors contribute to CHD development.
  • Key genes like NKX2-5, GATA4, and TBX5 are crucial for heart and vessel formation.

Purpose of the Study:

  • To summarize the associations between genetic variants in NKX2-5, GATA4, and TBX5 and specific CHD subtypes.
  • To explore the relationship between variant distribution and clinical phenotypes.
  • To investigate the structural implications of these genetic variations.

Main Methods:

  • Literature review summarizing genetic variant data for NKX2-5, GATA4, and TBX5.
  • Analysis of variant locations within gene domains and exons.
  • Structure-modelling to assess DNA-binding ability and stability of mutated residues.

Main Results:

  • NKX2-5 variants in the tinman and homeodomains are linked to atrial septal defects (ASD) and atrioventricular (AV) block.
  • GATA4 variants at terminal ends are associated with ventricular septal defects (VSD).
  • TBX5 variants in specific exons (3, 4, 5, 7) strongly correlate with Holt-Oram syndrome (HOS).
  • Mutated residues retain DNA-binding ability and structural stability.

Conclusions:

  • Variant distribution in NKX2-5, GATA4, and TBX5 is tightly linked to particular CHD subtypes.
  • Structural integrity of these genes is maintained despite mutations.
  • Gene structure analysis may aid in predicting high-risk infants for specific CHD subtypes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
73
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Genetic Lingo01:11

Genetic Lingo

Overview
117.0K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
94
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.1K